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Diverse Mechanisms of 
Trinucleotide Repeat Disorders: 
An Exploration of Fragile X 
Syndrome and Huntington’s 
Disease
Cara strobel
Trinucleotide repeat disorders are an umbrella group of genetic diseases that have been well described clinically for a long time; however, the scientific community is only beginning to understand  their molecular basis. They are classified in two basic groups depending on the location 
of the relevant triplet repeats in a coding or a non-coding region of the genome. 
Repeat expansion past a disease-specific threshold results in molecular and cellular 
abnormalities that manifest themselves as disease symptoms. Repeat expansion is 
postulated to occur via slippage during DNA replication and/or transcription-
mediated DNA repair. Trinucleotide repeat disorders are characterized by genetic 
anticipation, which is defined by the increasing severity and earlier onset of a 
disease as it is inherited through consecutive generations. Through the analysis of 
Huntington’s disease  as an example of coding trinucleotide repeat disorder and 
Fragile X Syndrome as an example of non-coding trinucleotide repeat disorder, 
this work will explore the nature of this devastating group of diseases and the 
underlying basic molecular processes that construct them. Despite sharing key 
characteristics, these diseases differ significantly in the wide variety of havoc 
the repeat expansions can create depending on their location and the nature of 
the disrupted function. Understanding of the mechanism and specifics of each 
individual disease remains critical for development of proper therapies. 
Introduction
Trinucleotide repeat disorders are an umbrella group of genetic diseases that 
have been well described clinically for a long time; however, their molecular 
basis is still being elucidated. For example, Huntington’s disease (HD), one of 
the most widely known diseases associated with trinucleotide repeats, was first 
described  at the end of the 19th century, whereas the gene associated with this 
disorder was not discovered until the mid nineties of the 20th century (Chial, 
2008). Currently, all known trinucleotide disorders are classified in two basic 
groups depending on the location of the relevant triplet repeats in a coding 
or non-coding region of the genome. The genome of a human cell could be 
viewed as a sum of the cellular DNA comprising its genetic blueprint. Coding 
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regions involve very small fraction of the human genome 
that codes for proteins. Protein molecules build most of the 
organism structures and function as working horses performing 
molecular work that underlies cellular physiology. The vast 
majority of human DNA does not code for proteins, thus 
comprising non-coding regions involved in orchestrating the 
regulation of protein expression. The execution of the genetic 
program of the human cell depends on the proper function 
of both coding and non-coding regions of the genome. As a 
general principle, mutations in coding regions inflict changes 
of protein sequence and function, whereas mutations in non-
coding regions result in changes in the protein levels in the cell. 
Cells that are forced to work with altered or missing proteins 
exhibit abnormal physiology which on the organismal level is 
observed as disease symptoms.
Trinucleotide repeat disorders associated with coding regions 
include Huntington’s disease, Kennedy disease (Spinobulbar 
muscular atrophy), Haw-River Syndrome (Dentatorubral-
pallidoluysian atrophy) and five different types of Spinocerebellar 
ataxia. These diseases are also called polyglutamine diseases 
since all of them are associated with repeats of CAG triplets, 
which code for the amino acid glutamine. The pathology of 
all diseases in this group involves pathologies of the nervous 
system (Cummings and Zoghbi, 2000). 
Non-coding trinucleotide repeat disorders include Fragile X 
syndrome (associated with CGG repeats), Fragile XE syndrome 
(associated with GCC repeats), Friedreich’s ataxia (associated 
with GAA repeats), Myotonic Dystrophy (associated with 
CTG repeats), Spinocerebellar ataxia type 8 (associated with 
CTG repeats) and Spinocerebellar ataxia type 12 (associated 
with CAG repeats). Some of these disorders have been found 
to be neurodegenerative (Fragile X syndrome) while others, like 
myotonic dystrophy, affect muscle maintenance (Cummings 
and Zoghbi, 2000). 
Both groups of trinucleotide repeat disorders share common 
molecular features and most likely common mechanisms 
of repeat extension that are directly connected to the flow 
of genetic information in the cell. The DNA as a genetic 
blueprint is securely stored in the nucleus of the human cell 
and constantly monitored for its integrity. DNA replication, 
or DNA copying, takes place only before cellular division, to 
ensure that exactly the same genetic information is passed to the 
resulting offspring. Since proteins are needed continuously in 
the cell and the protein synthesizing machinery resides outside 
the nucleus, the genetic code is first copied into messenger 
RNA (mRNA) via a process called transcription. mRNAs are 
easily transported outside the nucleus and then recognized by 
the protein-making machines, the ribosomes, which translate 
the genetic information into proteins. Any changes that 
take place in the DNA blueprint such as mutations can be 
subsequently traced as changes in RNA and could potentially 
affect the integrity of the corresponding proteins.
All trinucleotide repeat disorders are associated with genes 
whose natural sequence includes multiple repeats. By their 
nature, repeats present a challenge for the cellular machinery 
handling the DNA or RNA molecules that contain them. One 
can rationalize the challenge by comparing the error rates of 
reading a page of repetitive text versus a page of non-repetitive 
text. The likelihood of skipping or repeating a line by accident 
is much greater for repetitive text than for the non-repetitive 
one. Similarly, when DNA repeats are replicated or transcribed, 
there is an increased chance of error that will result in change 
of the number of repeats. Trinucleotide repeat disorders are 
associated with repeat expansion. One proposed mechanism 
for the expansion has to do with strand slipping during DNA 
replication. Petruska, Hartenstine, and Goodman (1997) con-
ducted experiments with synthetic DNA containing trinucleo-
tide repeats and concluded that repeated sequences promote 
slippage via DNA looping. In a region of repeats, separation of 
the strands of DNA during replication can cause single-strand-
ed loops of repeats. When the looping takes place in parental 
DNA strand, the net result is reduction of the number of the 
repeats, simply because the repeats in the loop are skipped and 
not copied. If the newly replicating DNA loops out, the net 
result is repeat expansion since the repeats in the loop are cop-
ied twice. Alternative mechanism involves transcription-medi-
ated DNA repair pathways. Repeated sequences confuse the 
transcription machinery, which stalls and activates the DNA 
repair systems of the cell that occasionally make an error lead-
ing to repeat expansion. It is thought that the DNA slippage 
mechanism is prevalent in actively dividing cells, whereas the 
transcription-mediated DNA repair mechanism is prevalent in 
non-dividing cells, such as neurons, for example. The repeat 
expansion can take place in both somatic and germ cells, thus 
offering an explanation why the severity of the trinucleotide re-
peats disorders can sometimes change during the course of the 
disease in a particular individual and between generations. As 
a consequence of the described molecular events, trinucleotide 
repeat disorders share a common phenomenon named genetic 
anticipation, which is defined by the increasing severity and 
earlier onset of a disease as it is inherited through consecutive 
generations.
Through the analysis of Huntington’s disease  as an example of 
coding trinucleotide repeat disorder and Fragile X Syndrome 
as an example of non-coding trinucleotide repeat disorder,  this 
work will explore the nature of this devastating group of diseases 
and the underlying basic molecular processes that construct 
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them. Despite sharing key characteristics, such as trinucleotide 
repeat expansion and genetic anticipation, these diseases differ 
significantly in the wide variety of havoc the repeat expansions 
can create depending on their location and the nature of the 
disrupted function. 
Molecular Mechanisms and Pathology of huntington’s 
Disease
Huntington’s disease (HD) is one of the best known disorders 
within the polyglutamine diseases. It is an autosomal dominant 
disorder caused by the polyglutamine repeat expansion within 
the huntingtin protein (Htt) encoded by the IT15 (interesting 
transcript 15) gene located on chromosome 4. Individuals are 
affected by HD even if they inherit only a single abnormal 
copy of the gene. HD affects 1/10,000 individuals and is 
characterized by neurodegeneration. Specifically, it involves the 
depletion of neurons and an increased number of glial cells, 
primarily in the striatum region of the brain associated with 
movement planning, working memory, and decision-making. 
Other regions like the cortex, thalamus, and subthalamic 
nucleus are also affected (Sadri-Vakili and Cha, 2006). This 
atrophy of certain brain regions causes profound effects on 
the individual, but not until the fourth or fifth decade of life. 
An unfortunate truth of this, however, is that by the time the 
disease presents itself in symptoms, the mutated gene has likely 
been passed on to the next generation.
The three major types of symptoms associated with Hunting-
ton’s are behavioral, motor, and cognitive. The disease presents 
itself as a progressive deterioration, usually taking the life of the 
affected individual 15-20 years after diagnosis (Longshore and 
Tarleton, 1996). Behavioral symptoms are the first to present 
themselves in the form of mood changes. Next, motor symp-
toms begin to occur in the extremities through involuntary 
twitching and loss of coordination. In conjunction with the 
motor symptoms, cognitive symptoms become more notice-
able and complicated tasks become progressively more difficult 
to think through. As the disease advances, the severity of these 
symptoms becomes more intense to the point that the involun-
tary movements appear more like a frantic dancing as opposed 
to twitching. Changes in mood continue to develop though 
some people with HD become more apathetic in regards to 
their disease, losing interest in activities they used to enjoy. 
And finally, it becomes progressively harder for HD patients to 
think clearly as the disease worsens. In late stage HD, patients 
lose their involuntary movements and begin to experience ri-
gidity and the lack of ability to move voluntarily at all. 
It is well known in HD that the number of repeats is an 
important component of the disease. Huntingtin (Htt) is a 
natural protein found in numerous areas of the brain of all 
individuals. All of the Htt proteins have the polyglutamine 
repeats, but the number of repeats can affect the onset, 
progression, and overall severity of the disease (Figure 1). Normal 
individuals have between 7-34 CAG repeats. Individuals with 
more than 40 repeats develop HD. If the number of repeats 
is over 70, a juvenile onset of HD is very likely. It has been 
observed in clinical settings that the severity and percentage of 
early onset of HD increases as the mutation is passed through 
Figure 1. Htt gene structure and relationship to hd pathology. 
CAG repeat expansions related to HD are located within the protein-coding 
sequence (in gray) of the Htt gene, thus affecting the sequence and the 3D 
shape of the protein. In contrast, the regulatory sequences of the Htt gene 
(Promoter (designated with P), Terminator (designated with T) and the 
UnTranslated Regions at the beginning of the gene (5’UTR) and the end 
of the gene (3’UTR)) are unaffected. The severity of the disease is directly 
correlated to the number of CAG repeats as depicted by the inverted triangle. 
families (Longshore and Tarleton, 1996). There have also been 
differences in severity and onset depending on the parent from 
which the mutation was inherited. In HD, if the abnormal 
allele is inherited from the father, there is an increased risk of 
earlier onset, presumably from an expansion that had grown 
from the father’s generation to his child’s. It was found that the 
alleles involved are more unstable when transmitted through 
sperm as opposed to the egg, leading to changes in the number 
of repeats expanding through sperm transmission (Longshore 
and Tarleton, 1996). 
There are several ideas of how glutamine expansion within the 
huntingtin protein causes HD. It is important to note, how-
ever, that neither mechanism is not fully understood. It has 
been proposed that the glutamine repeats cause a change in 
function of the Htt gene. For example, the mutant Htt protein 
binds to an intracellular protein HAP-1, to which the natural 
form of the protein would normally not bind. The HAP-1 pro-
tein has been noted to be involved in trafficking of vesicles and 
organelles, including mitochondria whose major function is 
energy production in the cell. The Htt protein, though found 
all throughout the body, is present at high concentrations in 
the brain. It is also thought that inefficient energy production 
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contributes to HD pathology since HD-related neurodegen-
eration could be reversed experimentally by treating with drugs 
interfering with energy-associated signaling (Varma, H., et al., 
2007). Another idea for the effect the trinucleotide repeats 
have on Htt and subsequently the brain has to do with the 
way that the expansion affects protein folding, the process by 
which proteins adopt their 3D shape. When the Htt protein 
is misfolded, it gains a toxic function. The misfolded Htt pro-
tein has the potential to interact with nearby proteins that will 
cause selective degeneration and neuronal death (Cummings 
and Zoghbi, 2000). A second effect of the misfolded proteins is 
the potential for the formation of aggregates. The proteins at-
tach to one another and form groups that can affect the nuclear 
architecture and the functions that it carries out (Cummings 
and Zoghbi, 2000). 
Lastly, mutated Htt protein can alter transcription by interfer-
ing with histone modifications. Histone molecules are part of 
the efficient DNA packing in the cell. Strands of DNA wrap 
themselves around histone to become more compact when 
genes are not used (transcribed). When DNA needs to be tran-
scribed, the strength of the hold the histone has on the DNA 
weakens and the DNA can be more easily accessed to allow the 
genetic information to be used to make proteins. When the 
mutant Htt interacts with histones, chromatin becomes more 
compact, therefore inhibiting necessary transcription (Sadri-
Vakili and Cha, 2006). Changes in transcription regulation 
in the brain clearly have profound effects on brain function 
and degeneration, and they are found frequently in those in-
dividuals diagnosed with HD (Sadri-Vakili and Cha, 2006). It 
is quite possible that mutant Htt protein inflicts brain damage 
via multiple mechanisms since the Htt is a large multifunc-
tional protein in its natural form. Logically, when it does not 
work properly, multiple physiological circuits of the cell could 
be disrupted.
Molecular Mechanisms and Pathology of Fragile X 
Syndrome
Just as the mechanism for HD is speculated upon and not 
fully understood, mechanisms for a fellow trinucleotide repeat 
disorder, Fragile X Syndrome (FXS), are also the subject of 
intensive research. Since FXS was one of the first trinucleotide 
disorders to be recognized and studied, the mechanisms are 
much better understood. The FXS relevant repeat is located in 
the 5’ untranslated region (Figure 2) of the FMR1 (Fragile X 
Mental Retardation) gene on the X chromosome (Longshore and 
Tarleton, 1996), i.e. no changes in the protein itself are taking 
place, rather its amount is being changed. In contrast, the HD 
repeat is located in a translated region on chromosome 4, i.e. 
the defect alters the encoded protein directly introducing more 
glutamines. FXS is an X-linked dominant disorder that is one 
of the most commonly inherited forms of mental retardation, 
second only to Down syndrome. Since males have only one 
X-chromosome and females have two X-chromosomes, the 
disease manifests itself differently between males and females. 
Males usually display a significant intellectual impairment, but 
there is a range of severity. There are several distinctive physical 
features for FXS that include a long face, large ears, flat feet, 
and hyperflexible joints (National Fragile X Foundation, 
2012). In terms of behavioral symptoms, increased aggression, 
ADHD-like attention issues, and social anxiety are all common 
in males affected by FXS. Males pass the disease only to their 
daughters since they are the ones inheriting an X chromosome 
from their father, whereas male offspring inherit their father’s 
Y chromosome. In contrast, females can pass the disease to 
both sons and daughters and display less severe phenotypes 
as compared to their male counterparts. The differences in 
severity of the phonotype are at least in part associated with 
the X chromosome inactivation phenomenon in females. 
Each female cell randomly inactivates one X chromosome. 
If the inactivated chromosome contains a defective copy of 
the FRMP gene, then the cell will appear normal because 
the working X chromosome contains a functional copy of 
the gene. As a result, female bodies contain a variable mix of 
normal and defective cells, leading to a broad range of severity 
of the symptoms. Only one third of affected females have a 
significant intellectual disability and the behavioral symptoms 
are the same, but less severe than those affected males where 
all cells in the body have a defective X chromosome (National 
Fragile X Foundation, 2012).
FXS affects 1/1,250 males and 1/2,500 females and, like an 
HD, there is a range of repeats (Figure 2) that can cause the 
disorder (Timchenko and Caskey, 1996). Individuals with 
stable repeats that do not display the phenotype of FXS have 
repeats ranging from 6-46, and unaffected carriers have 50-200 
repeats. The unaffected carriers, who have the coding for the 
Figure 2. FMR1 gene structure and relationship to Fragile X pathology. 
CGG repeat expansions related to Fragile X syndrome are located within 
the regulatory 5’UTR sequence (in white, on the left) of the FMR1 gene, 
and do not affect the sequence and the 3D shape of the encoded protein. All 
regulatory sequences are labeled as described in the legend of Figure 1. The 
severity of the disease is directly correlated to the number of CGG repeats as 
depicted by the inverted triangle.
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premutation, can pass along the expansion to their children. 
Those individuals with over 200 repeats in the FMR1 gene will 
exhibit the described phenotype. Just like HD, FXS displays 
unusual inheritance patterns of the nucleotide expansion. In 
addition to genetic anticipation, FXS is characterized with a 
parent of origin phenomenon or Sherman Paradox (Timchenko 
and Caskey, 1996). When a male with premutation has 
children, he passes on the premutation with minimal if any 
change in the number of the repeats. If a female passes on 
premutation alleles, the section is very likely to expand and 
develop into a full mutation resulting in Fragile X syndrome. 
This phenomenon is attributed to differences in the processes 
of sperm and egg formation (Timchenko and Caskey, 1996). 
Some individuals can have the FXS mutation but show no 
symptoms, a phenomenon known as incomplete penetrance.
Similar to HD, FXS is associated with a particular gene; FMR1 
coding for FMRP, or fragile X mental retardation protein. In 
healthy individuals, FMRP is expressed in many tissues in 
the body with the highest levels in the neurons of the brain, 
testes and ovaries (Timchenko and Caskey, 1996). FMRP is an 
RNA-binding protein that shuttles between the nucleus and 
the cytoplasm presumably regulating the transport of specific 
mRNAs. In addition, FMRP has been found to associate with 
ribosomes in the dendritic protrusions of neurons, which 
suggests potential role in the translation of mRNAs specific 
for this area of the cell. FMRP interacts with several proteins; 
however the biological significance of the interactions is not 
understood (Cummings and Zoghbi, 2000: National Institutes 
of Health: FMR1, 2012). 
 The accumulation of trinucleotide repeats associated with FXS 
results in alteration of the expression of the FMR1 gene leading 
to limited or absent fragile X protein production in the cell 
proposed to lead to disrupted neuronal communication. Two 
mechanisms have been experimentally supported: 1) decreased 
efficiency of translation initiation, most likely caused by the 
repeats impeding the proper assembly of the ribosome on the 
FMR1 mRNA and 2) transcription silencing via methylation 
of the DNA region governing FMR1 transcription resulting in 
lack of FMR1 mRNA and thus lack of Fragile X protein. The 
second mechanism is observed only in patients with more than 
200 repeats (Timchenko and Caskey, 1996). 
Collectively, both mechanisms result in insufficient levels 
of FMRP necessary for proper functioning, thus neuronal 
abnormalities and loss are observed and mental retardation 
occurs (Cummings and Zoghbi, 2000; Longshore and Tarleton, 
1996). 
Do all trinucleotide diseases have a common mechanism?
An interesting comparison has been made between HD 
and FXS in terms of the underlying mechanisms. There is a 
difference in the way in which the mutation affects the primary 
function of those pathways. Fragile X syndrome results from 
a reduced level of the FMRP or loss of function; whereas 
Huntington’s disease results from changes in function of the 
associated protein (Cummings and Zoghbi, 2000; Longshore 
and Tarleton, 1996). In HD, the increase of the number of 
trinucleotide repeats causes the formation of aggregates and the 
acquisition of potentially toxic qualities that cause the neuronal 
death noted in the disorder. In FXS, the hypermethylation of 
the promoter region on the FMR1 gene causes a decrease in 
transcription, reducing the amount of FMRP which is vital 
for the proper development of neuronal tissue. It is the loss 
of function that causes the phenotype, not a gain in toxic 
function, as in the case of HD. 
Despite their extensive differences, there have been attempts to 
link the trinucleotide repeat disorders together mechanistically. 
For example, Kaplan, Itzkovitz, and Shapiro (2007) proposed 
a universal mechanism for trinucleotide disorders specifically 
referring to the size of the repeat and how that affects the 
onset of the disorder. They explained that patients with large 
nucleotide repeats are born with all relevant cells having a 
copy of the mutation and as the individual grew older, the 
toxic effects of the repeat’s misfolding or other behavior within 
the body grew progressively in numbers. There is a threshold 
for the amount of toxicity that is tolerated before phenotypic 
manifestations of the disorder begin to arise, and later in life 
with more and more developing due to these disorders, the 
phenotype begins to appear at these later points. Those with 
a greater number of repeats have a more severe display of the 
disorder and an earlier onset. According to their proposed 
mechanism, the trinucleotide repeat is more potent when it 
is longer and it therefore produces more drastic effects and 
quicker presentation. Though this mechanism does match 
the progression of HD, FXS is one trinucleotide disorder that 
does not manifest in this way. FXS presents itself from birth 
and does not progressively get worse. It very well may fit the 
mechanisms of other trinucleotide disorders, but one of the 
most well known of the group does not fit the proposed “all-
encompassing” theory. The clinical observations could be very 
well explained with the underlying molecular events. Since 
Fragile X is caused by lack of functional FMRP, the increase 
of the number of repeats will not change the condition simply 
because all FMRP has been lost already.
As illustrated through the analysis of two of the most prevalent 
disorders, the trinucleotide repeats in both coding and non-
coding regions of the genome do share several similarities, but 
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are very different mechanistically and phenotypically. They 
share the same basic type of molecular defect, but depending 
on the location of the trinucleotide repeat, the affected proteins 
can gain functionality in some cases, while in others can lose 
functionality, both of which can result in neuronal loss and 
subsequent symptoms. In addition, the natural functions of 
each affected protein are very different and their disruption 
results in widely varying abnormalities in cell physiology. 
Therefore, it seems unwise to try to offer a universal mechanism 
that would incorporate all aspects of the trinucleotide 
disorders and lead to development of common strategies for 
their management and treatment. Thus, it is highly unlikely 
that a universal mechanism would apply to all aspects of the 
various trinucleotide diseases solely based on the fact that they 
stem from the same type of mutation. Understanding of the 
mechanism and specifics of each individual disease remains 
critical for development of proper therapies. 
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